Fitt Insider MyFitnessPal Buys Cal AI, RFK Jr Okays Peptides, Temple Raises $54M for Brain Wearable
Mar 3, 2026
A quick rundown of a $54M raise for a forehead wearable that measures brain blood flow to track focus and fatigue. A shift in wearables toward cognitive training and stimulation pairing. MyFitnessPal’s acquisition of an AI-native nutrition tracker to deepen AI coaching and tracking. HHS plans to reclassify several peptides, changing compounding access and regulatory dynamics.
AI Snips
Chapters
Transcript
Episode notes
Wearables Moving From Steps To Brain Metrics
- Temple is building a forehead-worn wearable that continuously measures brain blood flow to quantify focus, fatigue, and cognitive resilience in real time.
- The device targets elite athletes and operators, positioning cognition metrics as the next layer beyond step counts and heart rate for high-performance optimization.
MyFitnessPal Doubles Down On AI Nutrition
- MyFitnessPal acquired AI-native CalAI, which generated over $40 million in sales and offers an AI-first simplified nutrition tracking experience.
- The move follows integrations with ChatGPT Health and acquisition of Intent, signaling consolidation of nutrition tools to reach younger users across 280M registered members.
HHS Move Could Reopen Peptide Access
- HHS plans to reclassify roughly 14 peptides from Category 2 back to Category 1, which could let licensed compounding pharmacies produce peptides like BPC-157 and CJC-1295 with a prescription.
- The change would expand access to tissue repair and performance therapies while raising regulatory and safety questions as telehealth and consumer optimization blur medical boundaries.